Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Chi Leung Chiang"'
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1105
Volume 15
Issue 4
Pages: 1105
This study aims to investigate the association of pre-treatment multi-phasic MR-based radiomics and dosimetric features with treatment response to a novel sequential trans-arterial chemoembolization (TACE) plus stereotactic body radiotherapy (SBRT) p
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Autor:
Tianzhu Lu, Eric Sze Chun Chau, Anne Wing Mui Lee, Jianji Pan, Wenqi Chen, Qiaojuan Guo, Peter Ho Yin Luk, Youping Xiao, Shao Hui Huang, Shaojun Lin, Brian O'Sullivan, Chi-Leung Chiang, Wai Tong Ng, Zhiyuan Xu, Jishi Li, Tiffany Sze Wai Ma, Horace Cheuk Wai Choi
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
This study aims to identify prognostic factors in nasopharyngeal carcinoma (NPC) to improve the current 8th edition TNM classification. A systematic review of the literature reported between 2013 and 2019 in PubMed, Embase, and Scopus was conducted.
Autor:
Kwok-Hung Au, Macy Tong, Yuk Tung, Cheuk-Wai Horace Choi, Wai Tong Ng, Kai-Cheong Roger Ngan, Chung-Hang James Chow, Chun-Yin Edwin Wong, Ka-On Lam, Ka-Wai Alice Cheung, Wing-Mui Anne Lee, Pui-Lam Yip, Chi-Leung Chiang, Shing-Fung Lee, K.M. Cheung, Ho-Fun Lee, Ming-Chun Darren Poon, Wing-Yu Jessica Lai, Po-Chung Sunny Chan
Publikováno v:
Cancers, Vol 13, Iss 4286, p 4286 (2021)
Cancers
Volume 13
Issue 17
Cancers
Volume 13
Issue 17
A nomogram was recently published by Sun et al. to predict overall survival (OS) and the additional benefit of concurrent chemoradiation (CCRT) vs. radiotherapy (RT) alone, in stage II NPC treated with conventional RT. We aimed to assess the predicto
Autor:
Shing Fung Lee, Horace C. W. Choi, Sik Kwan Chan, Ka On Lam, Victor H. F. Lee, Irene O. L. Wong, Chi Leung Chiang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectivesWe aimed to compare the economic value of chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody (mAb) against chemotherapy with bevacizumab (Bev, an anti-vascular endothelial growth factor mAb) as first-lin
Autor:
Chi Leung Chiang, Tai Chung Lam, Chung Bong James Li, Wing Sum Li, Sik-Kwan Chan, Yim Ping Yolanda Lee, Ka Wai Alice Cheung, James Chung Hang Chow, Po Chung Sunny Chan, Wai Man, Sarah Lee, Wing Yu Jessica Lai, Aya El Helali, Wai-Tong Ng, Feng-Ming Spring Kong, Dora LW Kwong, Wing Mui Anne Lee
Publikováno v:
Journal of Clinical Oncology. 40:e18029-e18029
e18029 Background: Patients with recurrent or metastatic nasopharyngeal cancer (R/M NPC) who failed platinum-based chemotherapy have poor prognoses. We report the clinical activity and safety of bintrafusp alfa, a first-in-class bifunctional fusion p
Autor:
Chi Leung Chiang, Wan Hang Keith Chiu, Wing Hang Vince Lau, Sik-Kwan Chan, Ann Shing Lee, Feng-Ming Spring Kong, Albert Chan
Publikováno v:
Journal of Clinical Oncology. 40:4091-4091
4091 Background: Previous studies proposed therapeutic synergy between loco-regional therapies and checkpoint inhibitors in hepatocellular carcinoma (HCC). We aimed to study the safety and efficacy of sequential transarterial chemoembolization (TACE)
Autor:
Sik-Kwan Chan, Wan Hang Keith Chiu, Ho Fun Victor Lee, Varut Vardhanabhuti, Tan To Cheung, Albert Chan, Stephen L. Chan, Pek-Lan Khong, Kelvin Kwok Chai Ng, Wai-Kay Seto, Feng-Ming Spring Kong, Chi Leung Chiang
Publikováno v:
Journal of Clinical Oncology. 40:e16176-e16176
e16176 Background: Dual-tracer positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose and 11C-acetate is increasingly used in the management of hepatocellular carcinoma (HCC). However, considering the high cost of dual-
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e35-e36
PURPOSE/OBJECTIVE(S) We reported the first study of combined stereotactic body radiotherapy and immunotherapy (SBRT-IO) in unresectable hepatocellular carcinoma (uHCC) and found this combination was synergistic and safe. Based on these results, we co
Publikováno v:
Cancers
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 931, p 931 (2021)
Simple Summary There is a growing body of literature demonstrating high cancer drug costs relative to the benefits provided to patients treated on a large scale. We examined the cost-effectiveness of atezolizumab–bevacizumab for the first-line trea